Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

6.94 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -97.54-91.373-92.996-93.017-76.726-65.327-57.492-60.445-65.56-55.979-64.933-47.428-43.401-30.717-25.766-23.873-18.943-18.424
Depreciation & Amortization 87.415.6167.5785.5433.7283.2142.9892.7862.7672.2362.4362.3311.4021.6240.8571.0240.937
Deferred Income Tax 00-54.0570.01900000000.8270001.75700
Stock Based Compensation 16.52416.12716.08616.79211.8118.8147.6958.9075.6755.6324.3413.3635.3171.8211.1881.070.7691.265
Change In Working Capital -10.264-36.451-11.27-4.462-10.121-24.404-0.601-7.765-9.537122.824-3.9597.29-0.275-3.36231.5540.280.617-1.617
Accounts Receivables 0.736-1.04-6.422-0.203-0.814-0.3175.5723.777-8.086-1.265-5.3760.0160.0130.08530.043-30.190.060.082
Change In Inventory 00-1.3340.2030.8140.317-5.572-3.7778.086006.6442.141-2.9984.233000
Change In Accounts Payables -1.3421.168-0.3172.186-2.517-0.3390.6950.714-0.9861.344-3.5073.130.0712.051-0.222-0.055-0.5330.625
Other Working Capital -9.658-36.579-4.531-6.648-7.604-24.065-1.296-8.479-8.551121.48-0.452-2.5-2.5-2.5-2.530.5251.09-2.324
Other Non Cash Items 34.19132.79652.5440.172.0263.8732.4361.7735.0132.1441.1570.4642.3750.101-0.0270.453-0.1660.022
Operating Cash Flow -82.219-102.3-74.077-72.92-67.467-73.316-44.748-54.541-61.62377.388-61.158-33.048-33.653-30.7558.573-19.456-16.699-17.817
Investing Activities:
Investments In Property Plant And Equipment -4.182-6.653-2.417-0.827-3.968-5.34-7.979-8.563-16.475-4.342-4.464-9.706-6.212-19.416-4.591-0.826-0.634-0.684
Acquisitions Net 00-0.07101.91500000-184.1670000-2.600
Purchases Of Investments 0000000000-116.97-184.167000000
Sales Maturities Of Investments 0000.4800061.54721.415147.64669.1910000000
Other Investing Activites 00-0.350.3980-0.165-0.361.24721.415147.646184.167-184.16700-0.904-2.60.5950
Investing Cash Flow -4.182-6.653-2.488-0.347-2.053-5.34-7.97952.9844.94143.304-52.243-193.873-6.212-19.416-4.591-3.426-0.039-0.684
Financing Activities:
Debt Repayment -0.026-0.026-0.694-0.024-0.024-0.024-0.023-0.023-0.022-0.022-0.021-12.737-0.02-0.02-0.02-0.02-0.018-0.019
Common Stock Issued 263.14813.92381.35353.7893.8111.946143.7112.362.692.106462.9011.642463.7252.1540000
Common Stock Repurchased 000000000000000000
Dividends Paid 000000000000000000
Other Financing Activities 013.92381.35353.7653.7871.9223.5682.3372.692.106-459.0841.642463.7252.15410.055229.7410.46.016
Financing Cash Flow 263.12213.89780.65953.7653.7871.922147.2562.3372.6682.0843.796-11.095463.7052.13410.035229.7210.3825.997
Other Information:
Effect Of Forex Changes On Cash -0.118-0.2190.124-0.1150.181-0.002-0.30700000000000
Net Change In Cash 176.603-95.2755.218-19.617-65.552-76.73694.2220.78-54.015222.776-109.605-238.016423.84-48.03714.017206.839-16.356-12.504
Cash At End Of Period 476.124299.521394.796397.207416.824482.376559.112464.89464.11518.125295.349404.954642.97219.13267.167253.1546.31162.667